Statin takers could cut heart attack risk with new fortnightly jab

For decades high-risk patients have relied on statins but trials show those injecting alirocumab while still taking their tablets had fewer major adverse cardiovascular events than those on statins alone. The new NHS therapy is given to those whose cholesterol remains dangerously high despite taking the maximum dose of statins, or who cannot tolerate the […]